Prophylaxis, Preemption and Drug Resistance in CMV Infection: Too Little, Too Much or Just Right?
Version of Record online: 22 SEP 2011
©Copyright 2011 The American Society of Transplantation and the American Society of Transplant Surgeons
American Journal of Transplantation
Volume 12, Issue 1, pages 13–14, January 2012
How to Cite
Fishman, J. A. (2012), Prophylaxis, Preemption and Drug Resistance in CMV Infection: Too Little, Too Much or Just Right?. American Journal of Transplantation, 12: 13–14. doi: 10.1111/j.1600-6143.2011.03764.x
- Issue online: 13 JAN 2012
- Version of Record online: 22 SEP 2011
- Received 25 July 2011, revised 9 August 2011 and accepted for publication 16 August 2011
- 4High incidence of anti-cytomegalovirus drug resistance among D+R— kidney transplant recipients receiving preemptive therapy. Am J Transplant 2011., , , et al.